Navigation Links
High Doses of Statins Tied to Less Arterial Plaque in Study
Date:11/15/2011

TUESDAY, Nov. 15 (HealthDay News) -- High doses of the cholesterol-lowering statins Crestor and Lipitor reduced the amount of plaque in coronary arteries and reversed the progression of coronary artery disease, new research shows.

The study included 1,385 patients who took either 40 milligrams (mg) of Crestor (rosuvastatin) or 80 mg of Lipitor (atorvastatin) daily and were followed for two years.

The major finding was that the amount of coronary artery plaque fell 0.99 percent with Lipitor and 1.22 percent with Crestor. The difference between the two drugs is not statistically significant, the researchers noted.

"Regression of plaque has been the holy grail of heart disease treatment, and in this trial more than two-thirds of the patients had regression," lead researcher Dr. Stephen J. Nicholls, cardiovascular director of the Cleveland Clinic Coordinating Center for Clinical Research in Ohio, said in an American Heart Association news release.

"It's a very positive outcome for patients and shows the benefits of high doses of statins," Nicholls added.

The findings were to be presented Tuesday at the American Heart Association annual meeting in Orlando, Fla., and are published in the New England Journal of Medicine. The study was funded by AstraZeneca, which markets Crestor.

Among the other study findings:

  • Crestor reduced total plaque in 71.3 percent of patients and Lipitor reduced total plaque in 64.7 percent of patients.
  • Average levels of "bad" low-density lipoprotein (LDL) cholesterol were 62.6 mg/dL in patients taking Crestor and 70 mg/dL in patients taking Lipitor.
  • Average levels of "good" high-density lipoprotein (HDL) cholesterol were 50.4 mg/dL in patients taking Crestor and 48.6 mg/dL in patients taking Lipitor.

"The differences between the two drugs were modest and the difference in HDL levels was less than we were anticipating based on previous studies," Nicholls said in the news release.

The patients in this study had undergone coronary angiography, usually because they'd experienced chest pain and had abnormal results on a stress test.

In previous studies of patients who had similar characteristics and took lower doses of statins, 15 percent to 20 percent suffered a heart attack or stroke or required angioplasty to open a clogged artery over two years of follow-up. The rate of such events among patients in this new study was less than half of that.

"Doctors have been reluctant to use high doses of statins, but in this study the drugs were safe, well-tolerated and had a profound impact on lipid levels, the amount of plaque in vessel walls and the number of cardiovascular events," Nicholls said.

More information

The American Academy of Family Physicians has more about coronary artery disease.

-- Robert Preidt

SOURCE: American Heart Association, news release, Nov. 15, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. ASTRO publishes supplement on protecting cancer patients by reducing radiation doses, side effects
2. Children with food allergies should carry 2 doses of emergency medicine
3. Botox reduces wrinkles even in less frequent doses
4. High doses of antioxidant supplements induce stem cell genetic abnormalities
5. Organic Clothing – Is Your Clothing Delivering Death in Small Doses?
6. Cumulative Radiation Doses Seen in Cardiac Imaging
7. High doses of ursodeoxycholic acid ineffective for NASH patients
8. Higher Statin Doses Linked to Fewer Heart Attacks, Stroke
9. Yale researchers find double doses of chicken pox vaccine most effective
10. Study confirms 2 vaccine doses protect children from chickenpox
11. Preparing Small Doses of Medication From Syringes Called Risky
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
High Doses of Statins Tied to Less Arterial Plaque in Study
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: